Genistein activates apolipoprotein A-I gene expression in the human hepatoma cell line Hep G2

J Nutr. 2000 Oct;130(10):2489-92. doi: 10.1093/jn/130.10.2489.

Abstract

Soy phytoestrogens have been shown to increase plasma levels of HDL cholesterol and apolipoprotein (apo) A-I, its major protein component, in animal studies and in some human studies. The human hepatoma cell line Hep G2 was used to study the effect of the phytoestrogens genistein and daidzein on apo A-I secretion and gene expression in liver cells. Both genistein and daidzein increased apo A-I secretion in a dose-dependent fashion. Apo A-I concentration in the media of treated cells was increased approximately fivefold by 10 micromol/L genistein (P: < 0.001) and approximately onefold by 10 micromol/L daidzein (P: < 0.001) compared with control cells. The effect of genistein on apo A-I secretion was similar to that observed with 17-beta-estradiol. Treatment of cells with genistein for 24 h increased the transcriptional activity of the apo A-I gene as measured by nuclear run-on assay. Transfection experiments with plasmids containing regulatory regions of the apo A-I gene cloned in front of the luciferase reporter gene indicated that the 5' region of the apo A-I gene contained between nucleotides -256 and -41 is responsible for the increased expression of this gene by genistein.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Apolipoprotein A-I / genetics*
  • Apolipoprotein A-I / metabolism
  • Carcinoma, Hepatocellular / metabolism*
  • Estradiol / pharmacology
  • Gene Expression / drug effects*
  • Genistein / pharmacology*
  • Humans
  • Isoflavones / pharmacology
  • Liver Neoplasms / metabolism*
  • Progesterone / pharmacology
  • Transfection
  • Tumor Cells, Cultured

Substances

  • Apolipoprotein A-I
  • Isoflavones
  • Progesterone
  • Estradiol
  • daidzein
  • Genistein